| Primary |
| Asthma |
45.4% |
| Chronic Obstructive Pulmonary Disease |
13.4% |
| Product Used For Unknown Indication |
10.3% |
| Drug Use For Unknown Indication |
4.1% |
| Fibromyalgia |
4.1% |
| Seasonal Allergy |
4.1% |
| Sinusitis |
4.1% |
| Asthma Exercise Induced |
2.1% |
| Dyspnoea |
2.1% |
| Glaucoma |
2.1% |
| Restrictive Pulmonary Disease |
2.1% |
| Bronchitis |
1.0% |
| Bronchospasm |
1.0% |
| Diabetes Mellitus |
1.0% |
| Exercise Induced Asthma |
1.0% |
| Multiple Allergies |
1.0% |
| Sarcoidosis |
1.0% |
|
| Pharmaceutical Product Complaint |
9.7% |
| Pneumonia |
9.7% |
| Urticaria |
9.7% |
| Chronic Obstructive Pulmonary Disease |
6.5% |
| Device Malfunction |
6.5% |
| Myocardial Infarction |
6.5% |
| Sinusitis |
6.5% |
| Withdrawal Syndrome |
6.5% |
| Acidosis |
3.2% |
| Anger |
3.2% |
| Asthma |
3.2% |
| Blood Pressure Increased |
3.2% |
| Brain Natriuretic Peptide Increased |
3.2% |
| Breast Cancer |
3.2% |
| Bronchitis |
3.2% |
| Cardiac Disorder |
3.2% |
| Cardiac Failure Congestive |
3.2% |
| Chest Discomfort |
3.2% |
| Coronary Artery Occlusion |
3.2% |
| Cough |
3.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
36.7% |
| Asthma |
30.0% |
| Fibromyalgia |
8.0% |
| Sarcoidosis |
5.1% |
| Migraine |
4.2% |
| Seasonal Allergy |
4.2% |
| Product Used For Unknown Indication |
2.5% |
| Emphysema |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Diabetes Mellitus |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Multiple Allergies |
0.8% |
| Back Pain |
0.4% |
| Bronchitis |
0.4% |
| Dizziness |
0.4% |
| Glaucoma |
0.4% |
| Pain In Extremity |
0.4% |
| Palpitations |
0.4% |
| Psychomotor Hyperactivity |
0.4% |
| Tremor |
0.4% |
|
| Tremor |
29.3% |
| Sinusitis |
19.5% |
| Pneumonia |
12.2% |
| Dizziness |
4.9% |
| Gingival Pain |
4.9% |
| Blood Pressure Increased |
2.4% |
| Cardio-respiratory Arrest |
2.4% |
| Cataract |
2.4% |
| Drug Hypersensitivity |
2.4% |
| Dyspnoea |
2.4% |
| Hypersensitivity |
2.4% |
| Muscle Spasms |
2.4% |
| Oropharyngeal Discomfort |
2.4% |
| Overdose |
2.4% |
| Palpitations |
2.4% |
| Panic Reaction |
2.4% |
| Staphylococcal Infection |
2.4% |
|
| Concomitant |
| Asthma |
24.2% |
| Product Used For Unknown Indication |
19.3% |
| Drug Use For Unknown Indication |
14.3% |
| Chronic Obstructive Pulmonary Disease |
5.5% |
| Hypertension |
4.4% |
| Pain |
3.6% |
| Gastrooesophageal Reflux Disease |
3.3% |
| Depression |
3.2% |
| Hypersensitivity |
2.6% |
| Premenstrual Syndrome |
2.4% |
| Multiple Allergies |
2.3% |
| Osteoporosis |
2.2% |
| Acne |
2.0% |
| Back Pain |
1.9% |
| Migraine |
1.7% |
| Contraception |
1.5% |
| Emphysema |
1.5% |
| Constipation |
1.4% |
| Muscle Spasms |
1.4% |
| Osteoarthritis |
1.3% |
|
| Weight Decreased |
11.0% |
| Wheezing |
8.8% |
| Dyspnoea |
7.4% |
| Weight Increased |
7.4% |
| Deep Vein Thrombosis |
6.3% |
| Pharmaceutical Product Complaint |
6.3% |
| Asthma |
4.8% |
| Anaphylactic Reaction |
4.4% |
| Drug Ineffective |
4.4% |
| Vomiting |
4.4% |
| Tremor |
4.0% |
| Vision Blurred |
4.0% |
| Nausea |
3.7% |
| Product Quality Issue |
3.7% |
| Pulmonary Embolism |
3.7% |
| Sinusitis |
3.7% |
| Urinary Tract Infection |
3.3% |
| Pain |
2.9% |
| Palpitations |
2.9% |
| Vertigo |
2.9% |
|
